• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉输注胰岛素以模拟皮下吸收。生物利用度和代谢后遗症。

Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.

作者信息

Watanabe R M, Vølund A, Bergman R N

机构信息

University of Southern California School of Medicine, Department of Physiology and Biophysics, Los Angeles 90033.

出版信息

Diabetes Care. 1991 Nov;14(11):1021-30. doi: 10.2337/diacare.14.11.1021.

DOI:10.2337/diacare.14.11.1021
PMID:1797482
Abstract

OBJECTIVE

To determine the bioavailability and bioactivity of subcutaneously injected insulin.

RESEARCH DESIGN AND METHODS

A randomized block design with six male mongrel dogs as subjects. In protocol 1, purified pork insulin was infused intravenously to simulate the pattern of appearance in the blood that would have been expected from subcutaneous injection. Three intravenous doses (0.05, 0.10, and 0.15 U/kg) were infused on separate days in a pattern (0-300 min) designed to approximately simulate the absorption rate of subcutaneously injected insulin. In protocol 2, interscapular subcutaneous injections of pork insulin at 0.10 U/kg were made.

RESULTS

Integrated insulin, decrement in plasma glucose, and maximal glucose clearance for subcutaneous injection experiments were similar to intravenous infusion of equal dose (P greater than 0.10) but significantly different from low-dose infusions (P less than 0.025). Similar results were observed for hepatic glucose output and glucose uptake. Hypoglycemia elicited counterregulatory responses that appeared to be under a threshold differentiated at a plasma glucose of approximately 3 mM. Integrated insulin was plotted against insulin dose to create dose-response curves for intravenous data. The curve was then used to predict the actual appearance rate of insulin in plasma for subcutaneous injection. The estimated bioavailability of subcutaneous insulin was 103.0 +/- 10.5% of the injected dose.

CONCLUSIONS

We concluded that, in dogs, insulin delivered subcutaneously in the interscapular area is not significantly degraded before absorption, resulting in metabolic effects equal to intravenous insulin infusion of equivalent dose.

摘要

目的

测定皮下注射胰岛素的生物利用度和生物活性。

研究设计与方法

采用随机区组设计,以6只雄性杂种犬为研究对象。在方案1中,静脉输注纯化的猪胰岛素,以模拟皮下注射后预期的血药浓度变化模式。在不同日期分别静脉输注3种剂量(0.05、0.10和0.15 U/kg),输注模式(0 - 300分钟)旨在大致模拟皮下注射胰岛素的吸收速率。在方案2中,于肩胛间皮下注射0.10 U/kg的猪胰岛素。

结果

皮下注射实验的整合胰岛素、血糖降低幅度和最大葡萄糖清除率与等剂量静脉输注相似(P大于0.10),但与低剂量输注显著不同(P小于0.025)。肝葡萄糖输出和葡萄糖摄取也观察到类似结果。低血糖引发的反调节反应似乎在血浆葡萄糖约为3 mM时的一个阈值以下出现。将整合胰岛素与胰岛素剂量作图,以生成静脉注射数据的剂量反应曲线。然后用该曲线预测皮下注射时胰岛素在血浆中的实际出现速率。皮下胰岛素的估计生物利用度为注射剂量的103.0 +/- 10.5%。

结论

我们得出结论,在犬中,肩胛间区域皮下注射的胰岛素在吸收前未显著降解,产生的代谢效应与等剂量静脉输注胰岛素相当。

相似文献

1
Intravenous insulin infusion to simulate subcutaneous absorption. Bioavailability and metabolic sequelae.静脉输注胰岛素以模拟皮下吸收。生物利用度和代谢后遗症。
Diabetes Care. 1991 Nov;14(11):1021-30. doi: 10.2337/diacare.14.11.1021.
2
Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.吸入胰岛素与吸收促进剂联合使用时代谢效应的个体内变异性。
Diabetes Care. 2000 Sep;23(9):1343-7. doi: 10.2337/diacare.23.9.1343.
3
Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.持续生理性高胰岛素血症对正常人和糖尿病患者葡萄糖动力学及反调节激素的影响。
J Clin Invest. 1979 May;63(5):849-57. doi: 10.1172/JCI109384.
4
Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs.高胰岛素血症对清醒犬随后低血糖激素反应的影响。
Am J Physiol. 1993 May;264(5 Pt 1):E748-55. doi: 10.1152/ajpendo.1993.264.5.E748.
5
Evidence that carotid bodies play an important role in glucoregulation in vivo.有证据表明,颈动脉体在体内葡萄糖调节中发挥重要作用。
Diabetes. 2000 Sep;49(9):1434-42. doi: 10.2337/diabetes.49.9.1434.
6
The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans.不同胰岛素水平对正常人体对等效低血糖的激素和代谢反应的影响。
Diabetes. 1993 Feb;42(2):263-72. doi: 10.2337/diab.42.2.263.
7
Does insulin species modify counterregulatory hormone response to hypoglycemia?
Diabetes Care. 1991 Aug;14(8):728-31. doi: 10.2337/diacare.14.8.728.
8
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.皮下注射短效胰岛素类似物后,病程短且残余胰岛β细胞功能的胰岛素依赖型糖尿病患者餐后代谢控制得到改善。
Diabetes Care. 1995 Nov;18(11):1452-9. doi: 10.2337/diacare.18.11.1452.
9
Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response.胰岛内高胰岛素血症会抑制胰高血糖素对低血糖的反应,尽管自主神经反应完好。
Diabetes. 2002 Apr;51(4):958-65. doi: 10.2337/diabetes.51.4.958.
10
Influence of circulating epinephrine on absorption of subcutaneously injected insulin.循环肾上腺素对皮下注射胰岛素吸收的影响。
Diabetes. 1988 Jun;37(6):694-701. doi: 10.2337/diab.37.6.694.

引用本文的文献

1
Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling.通过全身体生理模型预测皮下给予单克隆抗体后的药代动力学。
J Pharmacokinet Pharmacodyn. 2020 Oct;47(5):385-409. doi: 10.1007/s10928-020-09691-3. Epub 2020 Jun 4.
2
Mechanistic determinants of biotherapeutics absorption following SC administration.皮下给药后生物治疗药物吸收的机制决定因素。
AAPS J. 2012 Sep;14(3):559-70. doi: 10.1208/s12248-012-9367-0. Epub 2012 May 23.